Paper · 41424170
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder Variant.
Banaszak LG and 15 others. Am J Med Genet A, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder Variant. Papers, record 41424170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41424170
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Telomere | Major topic |
| DNA Helicases | Major topic |
| Humans | |
| Female | |
| Male | |
| Heterozygote | |
| Adult | |
| Founder Effect | |
| Middle Aged | |
| Germ-Line Mutation | |
| Genetic Predisposition to Disease | |
| Child | |
| Telomere Shortening | |
| Adolescent | |
| Telomere Homeostasis | |
| Child, Preschool | |
| Aged | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| Robert and Kate Niehaus Center for Inherited Cancer Genomics | PubMed | PubMed | |||
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,418,648 | Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. | Haematologica | 2016 | https://conductscience.org/library/papers/27418648 | PubMed |
| 2 | 25,607,374 | Rare variants in RTEL1 are associated with familial interstitial pneumonia. | Am J Respir Crit Care Med | 2015 | https://conductscience.org/library/papers/25607374 | PubMed |
| 3 | 25,741,868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Genet Med | 2015 | https://conductscience.org/library/papers/25741868 | PubMed |
| 4 | 34,340,209 | The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer? | J Natl Compr Canc Netw | 2021 | https://conductscience.org/library/papers/34340209 | PubMed |
| 5 | 36,845,387 | Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. | Front Genet | 2023 | https://conductscience.org/library/papers/36845387 | PubMed |
| 6 | 36,151,328 | Genetics of human telomere biology disorders. | Nat Rev Genet | 2023 | https://conductscience.org/library/papers/36151328 | PubMed |
| 7 | 30,272,225 | The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature. | J Natl Cancer Inst | 2018 | https://conductscience.org/library/papers/30272225 | PubMed |
| 8 | 32,561,545 | Human RTEL1 associates with Poldip3 to facilitate responses to replication stress and R-loop resolution. | Genes Dev | 2020 | https://conductscience.org/library/papers/32561545 | PubMed |
| 9 | 26,022,962 | Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis. | Eur Respir J | 2015 | https://conductscience.org/library/papers/26022962 | PubMed |
| 10 | 32,923,861 | Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors. | JCO Precis Oncol | 2019 | https://conductscience.org/library/papers/32923861 | PubMed |
1 to 10 of 44
See all 44 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RTEL1 | 51,750 | PubTator's text mining | https://conductscience.org/library/genes/51750 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41424170
GET https://conductscience.org/api/papers/v1/41424170/references?page=2